What question did this study set out to answer?

The research aimed to evaluate prognostic implications of TP53 mutation subtypes in mantle cell lymphoma.

December 8, 2025BloodOpen Access

Heterogeneous TP53 mutation subtypes define prognostic classification in Mantle Cell Lymphoma

View Full Paper

Ask AI

Bookmark

Authors

LWLingli WangPediatric Cardiology

Discussion

Member takes

Implication

Retrospective analysis identified risk stratification from TP53 mutations in mantle cell lymphoma, suggesting implications for therapeutic resistance and survival.

Key Points

The research aimed to evaluate prognostic implications of TP53 mutation subtypes in mantle cell lymphoma.
Retrospective analysis of 215 patients diagnosed with mantle cell lymphoma
Targeted sequencing of the TP53 gene performed for each case
Collected clinical characteristics and survival data for analysis
Utilized multivariable Cox proportional hazards modeling for statistical evaluation.
TP53 mutations correlated with aggressive disease features and therapeutic resistance
Missense variants predominated among mutations, with significant clustering in specific gene regions
A three-tier classification of TP53 mutations revealed variations in overall and progression-free survival.

Cite This Study

Lingli Wang (2025) studied this question.

synapsesocial.com/papers/69362f514fa91c937236d9d4 https://doi.org/10.1182/blood-2025-3589

View Full Paper

Ask AI

Bookmark

Implication

Retrospective analysis identified risk stratification from TP53 mutations in mantle cell lymphoma, suggesting implications for therapeutic resistance and survival.

Heterogeneous TP53 mutation subtypes define prognostic classification in Mantle Cell Lymphoma

Discussion

Member takes

Implication

Key Points

Cite This Study

Heterogeneous TP53 mutation subtypes define prognostic classification in Mantle Cell Lymphoma

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider